Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines

Author： Kano Yasuhiko   Akutsu Miyuki   Tsunoda Saburo   Izumi Tohru   Kobayashi Hiroyuki   Mano Hiroyuki   Furukawa Yusuke  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.25, Iss.1, 2007-02, pp. : 31-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human Leukemia and Lymphoma Cell Lines as Models and Resources

By  

Current Medicinal Chemistry, Vol. 15, Iss. 4, 2008-01 ,pp. : 339-359

Bentham Science Publishers

Access to resources Recommend Favorite

Depsipeptide (FK228) as a Novel Histone Deacetylase Inhibitor: Mechanism of Action and Anticancer Activity

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 10, 2007-10 ,pp. : 1062-1069

Bentham Science Publishers

Access to resources Recommend Favorite

Tumor-selective Cytotoxicity of a Novel Pentadiene Analogue on Human Leukemia/lymphoma Cells

By  

Clinical Cancer Drugs, Vol. 3, Iss. 2, 2016-10 ,pp. : 138-146

Bentham Science Publishers

Access to resources Recommend Favorite

Tumor-selective Cytotoxicity of a Novel Pentadiene Analogue on Human Leukemia/lymphoma Cells

By  

Clinical Cancer Drugs, Vol. 3, Iss. 2, 2016-10 ,pp. : 138-146

Bentham Science Publishers

Access to resources Recommend Favorite

Assessing Combinations of Cytotoxic Agents Using Leukemia Cell Lines

By  

Current Drug Targets, Vol. 8, Iss. 6, 2007-06 ,pp. : 765-771

Bentham Science Publishers

Access to resources Recommend Favorite